Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for January 03, 2012 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Ensil Canada Ltd. Markham, Ontario, Canada, Today Announced the Validation of a 5-Minute, Non-Invasive HIV Test at its Laboratories in Ontario, Canada
After several years of scientific and biomedical laboratory experiments, Ensil succeeds in developing a nanotechnology-based sensor to detect gp 21 and gp 27 HIV virus through urine. 
x-small text small text medium text large text


    MARKHAM, ON, January 03, 2012 /24-7PressRelease/ -- After several years of scientific and biomedical laboratory experiments, Ensil succeeds in developing a nanotechnology-based sensor to detect gp 21 and gp 27 HIV virus through urine.

"After several years of scientific and biomedical laboratory experiments to develop nanotechnology-based sensors and detectors, we are extremely proud to make this announcement," said Farsad Kiani, Presiden and CEO of Ensil Group of Companies.

Mr. Kiani continued, "When the Ensil Canada Ltd. HIV diagnostic device is commercialized and put on the market, high-risk groups may get tested at more convenient locations as a do-it-yourself, real-time, cost-effective way to test and receive their own test results in strictest confidence."

Ensil Canada Ltd. Chief Scientist and the Lead Project CSO added after the successful experiments with the antibody to HIV gp41, Ensil will try to validate the same results with its proprietary detection technology to detect gp120 so a wide range of HIV strain could be detected.

Ensil Canada Ltd., a member of Ensil group of companies (www.ensil.com) focuses on enhancing mission critical technologies in the areas of aerospace, defence, telecommunication and medical diagnostic equipment. Ensil's R&D divisions' mission is to develop new technologies or improve existing technologies through in-house research activities. After nearly 30 years of scientific and technological experience, Ensil has required resources to modify, re-design, reverse engineer or repair circuit boards and assemblies used in medical, industrial and military equipment.

For further information please contact us at: info@ensil.ca or visit us at www.ensil.ca.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Read more Press Releases from Louis Koikas:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Social Media:
Share or bookmark this story using Facebook, Twitter, Digg, and more.

Bookmark and Share
Press Release Contact Information:
Louis Koikas
Ensil Canada Ltd.

Senior VP
205 Torbay Road
Markham, Ontario
Canada L3R3W4
Voice: 905-479-6979
Fax: 905-479-3185
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.